Spotlight on the
news
of the Cimi

Ciminaires Logo Cimi Paris

« Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses »

Location : webminar Speaker : Dr. Mélanie Bruchard
The news of the cimi Logo Cimi Paris

The effectiveness of a vaccine against #HIV

29 October 2021

Dr behazine combadière, a lead investigator at the centre for immunology and infectious diseases @inserm is working on predicting the effectiveness of a vaccine against #hiv which is concurrently advancing the #covidvaccine development research.

The news of the cimi Logo Cimi Paris

Vaccine responses against SARS-CoV-2 variants examined in people with lupus

08 October 2021

The majority of people with systemic lupus erythematosus (SLE) who respond to messenger (m)RNA COVID-19 vaccines also generate an antibody response against emerging SARS-CoV-2 variants, albeit with reduced neutralizing activity against variants bearing the E484K mutation, researchers report.

Events Logo Cimi Paris

A personalized precision medicine approach is needed to treat Covid-19 as more than one type of “Cytokine storm” is induced by SARS-CoV-2

07 October 2021

The severe form of Covid-19 is known to be associated with the excessive elevation of many cytokines, a condition termed “cytokine storm”. Therapy with biological agents intended to block these cytokines, for example anti-interleukin-6 or anti-interleukin-1 antibodies, was already tried, albeit with a limited success.

Ciminaires Logo Cimi Paris

Residency and trafficking of ILC2 under stable and Th2-induced inflammatory conditions

Location : webinar Speaker : Maxime Petit (CIMI-paris)
The news of the cimi Logo Cimi Paris

Is it dangerous to be vaccinated if you have already had the coronavirus?

24 August 2021

A message received by the editorial staff of LCI.fr is concerned about the possible danger of a vaccine against Covid-19 for people already infected. We respond with Béhazine Combadière, director of research at Inserm.

The news of the cimi Logo Cimi Paris

Covid-19: a needle-free vaccination soon possible?

24 August 2021

To meet the demand for vaccines, and to avoid a possible shortage of needles and syringes, start-ups, with the support of certain countries such as Canada, are working on injection methods that are not intramuscular, but through the skin.

Events Logo Cimi Paris

Particularly active antibodies as a barrier to SARS-CoV-2

24 August 2021

Teams from the Pitié-Salpêtrière AP-HP hospital, Sorbonne University, Inserm and the Pasteur Institute have carried out work to study the role played by IgA-type antibodies in protecting the body against Covid-19 in the mucous membranes, particularly the respiratory tract.